Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Journal:
Journal of Clinical Oncology
Published:
DOI:
10.1200/jco.23.01965
Affiliations:
13
Authors:
17
Go to article
Institutions Authors Share
Copenhagen University Hospital (CUH), Denmark
6.166667
 0.36
Hollings Cancer Center, MUSC, United States of America (USA)
4.000000
 0.24
Oregon Health and Science University (OHSU), United States of America (USA)
3.000000
 0.18
Indiana University (IU), United States of America (USA)
2.000000
 0.12
Oslo University Hospital (OUS), Norway
1.000000
 0.06
University of Copenhagen (UCPH), Denmark
0.833333
 0.05
Interested in Oncology and Carcinogenesis?